OKG Capital
Overview
OKG Capital is an investment fund and venture capital firm that specializes in early-stage Med-Tech and Life Science companies. The firm is committed to supporting high-impact companies with strong social value, with a focus on chronic disease therapeutics and diagnostics, particularly in oncology. It primarily invests in Seed and Series A rounds in Europe and the United States. Its portfolio includes companies in drug discovery, advanced medical imaging, molecular diagnostics, and remote patient monitoring.
Portfolio Companies
5
Website
okgcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| iFAST Diagnostics | May 2026 | Early Funding | Co-investor |
| iQure Pharma | Jan 2025 | Series B | Co-investor |
| 52North | Dec 2024 | Series A | Co-investor |
| DeepLook Medical | Sep 2024 | Series A | Co-investor |
| DeepLook Medical | Feb 2024 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.